← Leaderboards
James Richardson
Advanced Bioscience Laboratories, Inc.
$33,534,082
Attributed
$33,534,082
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $9.4M · FY2012–23$10M$7.5M$5M$2.5M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$33,534,082 · 2
By mechanism
N01$33,534,082 · 2
Top collaborators
No co-investigators on record.
Most similar at Advanced Bioscience Laboratories, Inc.
Same institution · by research overlap
- Tmothy Fouts$548,977
Others in their field
Top investigators on “Contracts”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,154,975,474
- Leonard Freedman · Leidos Biomedical Research, Inc.$811,365,654
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Bambra Strokes · Ppd Development Lp$526,656,217
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
Research focus
ContractsServicesVaccinesCommunicable DiseasesCyclic GmpDevelopment PlansProduct DevelopmentClinical ResearchToxicologyNovel VaccinesUnited States Food And Drug AdministrationBioterrorismEmerging Communicable DiseasesVaccine DevelopmentNational Institute Of Allergy And Infectious DiseasePathogenDrug ResistanceBiological ProductsProgramsPre-ClinicalVaccine CandidateMalaria VaccinesDrug Resistant PathogenReagent
Grant awards (83)
Task X11: Product Development Plans and Feasibility Assessments$70,013
N01 · FY2023 · AI · contact PI
Task X20: Manufacture and Characterization Services for Vaccines and Other Biologics for Infectious Diseases$63,053
N01 · FY2023 · AI · contact PI
Task X18: Process Development and Early Reagent Manufacturing for Vaccines and Other Biologics$48,822
N01 · FY2023 · AI · contact PI
Task X19: GMP Manufacturing for a Malaria Vaccine$28,086
N01 · FY2023 · AI · contact PI
Task X12: Development of a Gonorrhea Vaccine$21,423
N01 · FY2023 · AI · contact PI
Task X7: Malaria Vaccines Stability Study$15,621
N01 · FY2023 · AI · contact PI
Task X8: Stability Testing of Malaria Vaccine$12,905
N01 · FY2023 · AI · contact PI
Task X17: OPTIMIZATION OF LYOPHILIZATION AND THERMAL STABILITY OF A RABIES VACCINE CANDIDATE$10,634
N01 · FY2023 · AI · contact PI
Task X16: Fecal Microbiota for Transplantation (FMT) Process Development$9,385
N01 · FY2023 · AI · contact PI
Task X5: Master Cell Bank for Chlamydia Trachoma Vaccine$9,253
N01 · FY2023 · AI · contact PI
Task X9: Agilvax Phage Display for Multiple Vaccine Candidates$8,224
N01 · FY2023 · AI · contact PI
Task X10: Manufacture and Characterization Services for Vaccines$2,924
N01 · FY2023 · AI · contact PI
Task X6: Development of Candida Vaccines$1,063
N01 · FY2023 · AI · contact PI
Task X20:Master Cell Banks$67,144
N01 · FY2021 · AI · contact PI
Task X18: Process Development and Early Reagent Manufacturing for Vaccines and Other Biologics$143,827
N01 · FY2019 · AI · contact PI
Task X7: Malaria Vaccines Stability Study$40,000
N01 · FY2019 · AI · contact PI
Task X18: Process Development and Early Reagent Manufacturing for Vaccines and Other Biologics$223,502
N01 · FY2018 · AI · contact PI
Task X8: Stability Testing of a Malaria Vaccine$177,903
N01 · FY2018 · AI · contact PI
Task X7: Malaria Vaccines Stability Study$143,055
N01 · FY2018 · AI · contact PI
Task 19: GMP Manufacturing for a Malaria Vaccine Phase I Trial$121,535
N01 · FY2018 · AI · contact PI
Task X16: Fecal Microbiota for Transplantation (FMT) Process Development$110,692
N01 · FY2018 · AI · contact PI
Task X20:Master Cell Banks$96,456
N01 · FY2018 · AI · contact PI
Task X12: Development of a Gonorrhea Vaccine$86,613
N01 · FY2018 · AI · contact PI
Task X18: Process Development and Early Reagent Manufacturing for Vaccines and Other Biologics$60,000
N01 · FY2018 · AI · contact PI
Task X10: Cell Bank Work for Agilvax$14,317
N01 · FY2018 · AI · contact PI
Task X11: Product Development Plans and Feasibility Assessments$431,854
N01 · FY2017 · AI · contact PI
Task X20:Master Cell Banks$275,146
N01 · FY2017 · AI · contact PI
Task X18: Process Development and Early Reagent Manufacturing for Vaccines and Other Biologics$265,405
N01 · FY2017 · AI · contact PI
Task X18: Process Development and Early Reagent Manufacturing for Vaccines and Other Biologics$250,000
N01 · FY2017 · AI · contact PI
Task X18: Process Development and Early Reagent Manufacturing for Vaccines and Other Biologics$250,000
N01 · FY2017 · AI · contact PI
Task X5: Master Cell Bank for Chlamydia Trachoma Vaccine$229,955
N01 · FY2017 · AI · contact PI
Task X12: Development of a Gonorrhea Vaccine$206,368
N01 · FY2017 · AI · contact PI
Task X7: Malaria Vaccines Stability Study$137,529
N01 · FY2017 · AI · contact PI
Task X11: Product Development Plans and Feasibility Assessments$107,963
N01 · FY2017 · AI · contact PI
Task X18: Process Development and Early Reagent Manufacturing for Vaccines and Other Biologics$100,000
N01 · FY2017 · AI · contact PI
Task X8: Stability Testing of a Malaria Vaccine$73,281
N01 · FY2017 · AI · contact PI
Task X17: OPTIMIZATION OF LYOPHILIZATION AND THERMAL STABILITY OF A RABIES VACCINE CANDIDATE$72,562
N01 · FY2017 · AI · contact PI
Task X16: Fecal Microbiota for Transplantation (FMT) Process Development$63,306
N01 · FY2017 · AI · contact PI
Task X1: Manufacture and Characterization Services for Vaccines and Biologics$2,114
N01 · FY2017 · AI · contact PI
COMPREHENSIVE RESOURCES FOR HIV MICROBICIDE AND BIOMEDICAL PREVENTION$3,272,890
N01 · FY2016 · AI · contact PI
Task 19: GMP Manufacturing for a Malaria Vaccine Phase I Trial$1,523,776
N01 · FY2016 · AI · contact PI
Task X18: Process Development and Early Reagent Manufacturing for Vaccines and Other Biologics$515,415
N01 · FY2016 · AI · contact PI
Task X20:Master Cell Banks$463,269
N01 · FY2016 · AI · contact PI
Task Order X5 Master Cell Bank for Chlamydia Trachoma Vaccine$457,655
N01 · FY2016 · AI · contact PI
Task X18: Process Development and Early Reagent Manufacturing for Vaccines and Other Biologics$200,000
N01 · FY2016 · AI · contact PI
Task X1: Manufacture and Characterization Services for Vaccines and Biologics$180,140
N01 · FY2016 · AI · contact PI
Task X18: Process Development and Early Reagent Manufacturing for Vaccines and Other Biologics$179,737
N01 · FY2016 · AI · contact PI
Task 7: Malaria Vaccines Stability Study$132,341
N01 · FY2016 · AI · contact PI
Task X2: Feasibility and PDP support for Malaria Vaccines$30,957
N01 · FY2016 · AI · contact PI
Task X9: Agilvax Phage Display for Multiple Vaccine Candidates$29,589
N01 · FY2016 · AI · contact PI
Task 13: Product Characterization and Process Development$13,404
N01 · FY2016 · AI · contact PI
COMPREHENSIVE RESOURCES FOR HIV MICROBICIDE AND BIOMEDICAL PREVENTION$3,208,819
N01 · FY2015 · AI · contact PI
Task X9: Agilvax Phage Display for Multiple Vaccine Candidates$1,505,999
N01 · FY2015 · AI · contact PI
Task Order 9 Master Cell Bank for Chlamydia Trachoma Vaccine$697,764
N01 · FY2015 · AI · contact PI
Task X17: OPTIMIZATION OF LYOPHILIZATION AND THERMAL STABILITY OF A RABIES VACCINE CANDIDATE$565,946
N01 · FY2015 · AI · contact PI
Task X11: Product Development Plans and Feasibility Assessments$539,817
N01 · FY2015 · AI · contact PI
Task X10: Cell Bank Work for Agilvax$391,378
N01 · FY2015 · AI · contact PI
Task X16: Fecal Microbiota for Transplantation (FMT) Process Development$320,094
N01 · FY2015 · AI · contact PI
Task X12: Development of a Gonorrhea Vaccine$284,135
N01 · FY2015 · AI · contact PI
Task X18: Process Development and Early Reagent Manufacturing for Vaccines and Other Biologics$258,490
N01 · FY2015 · AI · contact PI
Task X13: Product Characterization and Process Development$253,402
N01 · FY2015 · AI · contact PI
Task 13: Product Characterization and Process Development$252,854
N01 · FY2015 · AI · contact PI
Task X18: Process Development and Early Reagent Manufacturing for Vaccines and Other Biologics$250,000
N01 · FY2015 · AI · contact PI
Task X13: Product Characterization and Process Development$203,071
N01 · FY2015 · AI · contact PI
Task X1: Manufacture and Characterization Services for Vaccines and Biologics$132,097
N01 · FY2015 · AI · contact PI
Task X11: Product Development Plans and Feasibility Assessments$110,124
N01 · FY2015 · AI · contact PI
Task X11: Product Development Plans and Feasibility Assessments$107,965
N01 · FY2015 · AI · contact PI
Task X11: Product Development Plans and Feasibility Assessments$107,963
N01 · FY2015 · AI · contact PI
Task X11: Product Development Plans and Feasibility Assessments$106,884
N01 · FY2015 · AI · contact PI
Task X11: Product Development Plans and Feasibility Assessments$106,884
N01 · FY2015 · AI · contact PI
Task X6: Development of Candida Vaccines$23,398
N01 · FY2015 · AI · contact PI
Task X2: Feasibility and PDP support for RSV vaccines$2,374
N01 · FY2015 · AI · contact PI
COMPREHENSIVE RESOURCES FOR HIV MICROBICIDE AND BIOMEDICAL PREVENTION$3,199,963
N01 · FY2014 · AI · contact PI
Task X3: Production and Testing of Conjugate Cholera Vaccine$1,323,948
N01 · FY2014 · AI · contact PI
Task 7: Malaria Vaccines Stability Study$415,825
N01 · FY2014 · AI · contact PI
Task X8: Stability Testing of a Malaria Vaccine$399,898
N01 · FY2014 · AI · contact PI
Task X6: Development of Candida Vaccines$336,003
N01 · FY2014 · AI · contact PI
Manufacture and Characterization Services for Vaccines and Biologics$199,628
N01 · FY2014 · AI · contact PI
Task X2: Feasibility and PDP support for Chlamydia Vaccines$90,915
N01 · FY2014 · AI · contact PI
Task X2: Feasibility and PDP support for Malaria Vaccines$90,915
N01 · FY2014 · AI · contact PI
Task X2: Feasibility and PDP support for RSV vaccines$24,747
N01 · FY2014 · AI · contact PI
COMPREHENSIVE RESOURCES FOR HIV MICROBICIDE AND BIOMEDICAL PREVENTION$3,976,501
N01 · FY2013 · AI · contact PI
COMPREHENSIVE RESOURCES FOR HIV MICROBICIDE AND BIOMEDICAL PREVENTION$2,995,175
N01 · FY2012 · AI · contact PI